Actividades asistenciales

PIRROLOPIRIMIDINAMINAS COMO INHIBIDORES DEL SISTEMA DEL COMPLEMENTO
31/10/2022 - Compuestos de Fórmula (I) y sus sales farmacéuticamente aceptables, que son inhibidores del sistema del complemento. También, composiciones farmacéuticas que comprenden un compuesto con dichas...
NUEVOS INHIBIDORES MACROCÍCLICOS DE LA QUINASA DE LRRK2
09/03/2023 - Compuestos de fórmula (I): en donde R, X1, X2, X3, Z1, Z2, Z3, A y Ra son como se han definido en la descripción. Medicamentos.
PIRROLOPIRIMIDINAMINAS COMO INHIBIDORES DEL SISTEMA DEL COMPLEMENTO
31/10/2022 - Compuestos de Fórmula (I) y sus sales farmacéuticamente aceptables, que son inhibidores del sistema del complemento. También, composiciones farmacéuticas que comprenden un compuesto con dichas...
MONITORING METHOD AND MONITORING APPARATUS FOR CONVEYING DEVICE
12/03/2026 - Provided is a monitoring method for a conveying device. The method comprises: acquiring data concerning the conveying status of a conveying device; on the basis of the data, identifying carriers...
Transcriptomics and metabolomics analyses reveal the growth promoting effects of tobacco straw biochar on tobacco
29/09/2021 - La presente invención se relaciona con una composición de extractos de algas macroalgas que tiene un contenido de materia seca entre 18-36 %. Estos extractos preferentemente pertenecen a...
SYSTEM AND METHOD FOR PROVIDING HEALTH ADVICE
20/02/2026 - 이용자의 일상 생활에 있어서 얻어지는 생체 데이터를 이용자의 건강 유지 및 증진을 위해서 유효하게 활용할 수 있음과 함께, 이용자를 위해서...
INHIBIDORES DE LA PROTEÍNA TIROSINA FOSFATASA
24/09/2021 - Se proporcionan compuestos de la Fórmula <strong>I</strong> o un estereoisómero, tautómero, profármaco o sal aceptable desde el punto de vista farmacéutico de...
Pharmaceutical composition for treatment or prophylaxis of anhedonia
16/12/2025 - The present invention provides a pharmaceutical composition for treatment or prophylaxis of anhedonia, which contains a selective [delta] opioid receptor agonist as an active ingredient,...
RNA inhibitors for inhibiting insulin-lke growth factor 1 receptor expression
01/12/2025 - The present application relates to an RNA inhibitor for inhibiting the expression of insulin-like growth factor 1 receptor (IGF-1R) comprising an antisense strand, said antisense strand forming a...
Compounds and compositions for treating conditions associated with calcitonin receptor and/or amylin receptor activity
01/12/2025 - The present disclosure provides compounds for modulating calcitonin receptor and/or amylin receptor activity, as well as pharmaceutical compositions comprising the compounds disclosed herein. Also...
Quinazoline compound and pharmaceutical
16/12/2025 - The present invention provides a quinazoline compound having inhibitory activity of mPGES-1, which is represented by the general formula [1]: (wherein, R1is -NR6R7, alkoxy, cycloalkyl or alkyl; R2...
Nucleic acid molecules and uses thereof for non-viral gene therapy
16/12/2025 - The present disclosure provides nucleic acid molecules comprising a first inverted terminal repeat (ITR), a second ITR, and a genetic cassette encoding a target sequence. In some embodiments, the...